Related Experiment Video
Updated: Jul 15, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Surgical options in undifferentiated thyroid carcinoma
Brian Hung-Hin Lang1, Chung-Yau Lo
1Division of Endocrine Surgery, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong, SAR, China.
World Journal of Surgery
|May 8, 2007
Summary
Anaplastic thyroid cancer (ATC) is an aggressive cancer with poor prognosis. Multimodal therapy, including surgery, radiation, and chemotherapy, is recommended, but novel targeted therapies show promise for this difficult-to-treat malignancy.
Area of Science:
- Oncology
- Endocrinology
- Surgical Oncology
Background:
- Anaplastic thyroid cancer (ATC) is a rare and aggressive thyroid malignancy.
- Patients often present with advanced disease, metastases, and poor prognosis.
- Effective systemic therapies are lacking, necessitating multimodal treatment approaches.
Purpose of the Study:
- To review the current understanding of anaplastic thyroid cancer management.
- To highlight the challenges in treating this aggressive malignancy.
- To discuss the role of surgery and emerging targeted therapies.
Main Methods:
- Review of retrospective case series and cohort studies.
- Analysis of evidence for multimodal treatment including surgery, radiation, and chemotherapy.
- Exploration of novel molecular targeted therapies.
Main Results:
- Anaplastic thyroid cancer has a dismal prognosis with median survival of 2-12 months.
- Surgery can be beneficial for selected patients, especially when combined with adjuvant therapies.
- Preoperative radiotherapy and chemotherapy regimens have shown potential for local control.
- Novel molecular targeted therapies are under development with promising preliminary results.
Conclusions:
- Anaplastic thyroid cancer remains a challenging diagnosis with limited effective treatments.
- Multimodal therapy, including carefully selected surgical resection, plays a role in management.
- Emerging targeted therapies offer hope for improved outcomes in this aggressive cancer.
